Seegene's in-life PCR campaign is a global initiative designed to encourage regular testing for respiratory viruses, including COVID-19, flu and colds, to protect against infectious diseases. The aim is to contain the rapid spread and ensure a rapid return to normality by targeting people in community facilities such as schools and nursing homes, as well as people who have no symptoms.

Seegene will provide LabHouse with its Allplex™ SARS-CoV-2/FluA/FluB/RSV assay, which can simultaneously detect COVID-19, influenza A and B, and respiratory syncytial virus (RSV). The company will also provide the necessary PCR instruments and systems to meet the increased testing needs as part of the in-life PCR campaign. Seegene also plans to offer its fully automated PCR solution 'STARlet-AIOS' for convenient and high-throughput workflows.

LabHouse will take the clinical samples, perform the PCR testing procedures, and make the PCR results available to Grab drivers in the Vietnamese cities of Ho Chi Minh and Hanoi. Drivers can get tested at LabHouse or even hire a service representative to visit them for sampling at a specific time and place of their choosing. LabHouse is in talks with hospitals in other Vietnamese cities to expand its in-life PCR campaign.

"We have decided to launch the in-life PCR campaign with sea genes to preemptively address the global resurgence of COVID-19 triggered by new variants and increased travel," said Nguyen Khoi Do, CEO of LabHouse. "We hope that through regular testing, we can protect the health and safety of drivers and Grab users."